Actively Recruiting
Comparing Absorption of Enhanced and Standard Vitamin D3 and Omega-3 Supplements in Healthy Adults A Randomized Parallel-Group Study
Led by RDC Clinical Pty Ltd · Updated on 2026-09-10
160
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating how well supplements with and without absorption-enhancing technology are absorbed in healthy adults aged 18 and older. This study focuses on vitamin D3 and omega-3 supplements. It aims to compare the absorption levels of these nutrients using different formulations in a randomized, parallel-group design. Participants are divided into groups receiving either a single dose of omega-3 or daily vitamin D3 supplements. Part A includes two groups receiving a single 315mg dose of omega-3 and two groups taking 1000IU of vitamin D3 daily for 7 days. Part B involves two groups taking 1000IU of vitamin D3 daily for 6 weeks. Each group receives either an enhanced formulation or a comparator version. During the study, participants will have scheduled blood collections to measure nutrient absorption over time, including up to 7 days for vitamin D3 and up to 6 weeks in the extended phase. Researchers will monitor safety, tolerability, and demographic data. The primary outcomes focus on serumplasma absorption measured by area under the curve AUC for each supplement. The total study duration varies depending on the group assignment, with close monitoring throughout.
CONDITIONS
Brief Title
Supplementation Absorption Comparison
Research Team
D
David Briskey
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here